Is Kimberly Clark (KMB) Below Fair Value Following Arbex Going Independent?
Kimberly-Clark (KMB) is in focus after Arbex, its joint venture with Suzano, began operating as an independent tissue and hygiene company serving more than 70 markets worldwide, raising fresh questions for investors.
See our latest analysis for Kimberly-Clark.
At a share price of $108.35, Kimberly-Clark has seen its 30-day share price return of 6.78% and 90-day share price return of 9.62% contrast with a 1-year total shareholder return that is down 10.88%. This suggests recent momentum has picked up even as longer term performance remains weak.
If Kimberly-Clark’s recent move has you reassessing your watchlist, this could be a good moment to broaden your search with the 18 top founder-led companies
Kimberly-Clark now has a broader global footprint through Arbex and a long history selling everyday essentials, yet the stock’s mixed return profile tells a different story. Is this a strong business trading at a fair price today?
Most Popular Narrative: 5.5% Undervalued
The most followed narrative on Kimberly-Clark pegs fair value at $114.67 versus the last close of $108.35, suggesting modest undervaluation based on long term cash flow assumptions.
Disciplined cost management (including targeted SG&A savings, productivity initiatives delivering 5% to 6% of COGS, and digital/automation investments) is enhancing operating efficiency, providing earnings and margin tailwinds that support attainment of multi-year gross margin and operating profit milestones.
Want to see what sits behind that fair value for Kimberly-Clark? The narrative hinges on steady revenue lifts, fatter margins and a future earnings multiple that has to line up with those targets.
Result: Fair Value of $114.67 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Kimberly-Clark’s story could change quickly if competition from private labels pressures pricing or if concentrated exposure to North America weighs on growth expectations.
Find out about the key risks to this Kimberly-Clark narrative.
Next Steps
With mixed sentiment around Kimberly-Clark, this is a good time to look past the headlines, review the underlying data yourself and decide how the risk reward tradeoff feels for you, starting with the 2 key rewards and 2 important warning signs
Looking for more investment ideas beyond Kimberly-Clark?
If Kimberly-Clark has sharpened your focus on quality, do not stop here. Broaden your hunt for opportunities using tailored stock ideas from the Simply Wall Street Screener.
- Prioritize resilience with companies that pair modest volatility and solid fundamentals by searching through 84 resilient stocks with low risk scores.
- Target strong cash generation and balance sheets by scanning the solid balance sheet and fundamentals stocks screener (47 results) for businesses that may better match your comfort level.
- Hunt for future standouts before they are widely followed with the screener containing 20 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com